Scara5 Is a Ferritin Receptor Mediating Non-Transferrin Iron Delivery

被引:292
作者
Li, Jau Yi [1 ]
Paragas, Neal [1 ]
Ned, Renee M. [2 ,3 ]
Qiu, Andong [1 ]
Viltard, Melanie [1 ]
Leete, Thomas [1 ]
Drexler, Ian R. [1 ]
Chen, Xia [1 ]
Sanna-Cherchi, Simone [1 ]
Mohammed, Farah [1 ]
Williams, David [1 ]
Lin, Chyuan Sheng [1 ]
Schmidt-Ott, Kai M. [1 ,4 ]
Andrews, Nancy C. [5 ,6 ]
Barasch, Jonathan [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, Div Renal, New York, NY 10032 USA
[2] McKing Consulting Corp, Atlanta, GA 30341 USA
[3] Ctr Dis Control & Prevent, Natl Off Publ Hlth Genom, Atlanta, GA 30329 USA
[4] Max Delbruck Ctr Mol Med, Charite Berlin, Dept Nephrol & Hypertensiol, D-13125 Berlin, Germany
[5] Duke Univ, Sch Med, Dept Pediat & Pharmacol, Durham, NC 27708 USA
[6] Duke Univ, Sch Med, Dept Canc Biol, Durham, NC 27708 USA
关键词
HUMAN ERYTHROID PRECURSORS; SERUM FERRITIN; URETERAL BUD; DEVELOPMENTAL-CHANGES; CELL-PROLIFERATION; INTRACELLULAR IRON; KIDNEY DEVELOPMENT; RAT HEPATOCYTES; TISSUE FERRITIN; MOUSE-BRAIN;
D O I
10.1016/j.devcel.2008.12.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Developing organs require iron for a myriad of functions, but embryos deleted of the major adult transport proteins, transferrin or its receptor transferrin receptor1 (TfR1(-/-)), still initiate organogenesis, suggesting that non-transferrin pathways are important. To examine these pathways, we developed chimeras composed of fluorescence-tagged TfR1(-/-) cells and untagged wild-type cells. In the kidney, TfR1(-/-) cells populated capsule and stroma, mesenchyme and nephron, but were underrepresented in ureteric bud tips. Consistently, TfR1 provided transferrin to the ureteric bud, but not to the capsule or the stroma. Instead of transferrin, we found that the capsule internalized ferritin. Since the capsule expressed a novel receptor called Scara5, we tested its role in ferritin uptake and found that Scara5 bound serum ferritin and then stimulated its endocytosis from the cell surface with consequent iron delivery. These data implicate cell type-specific mechanisms of iron traffic in organogenesis, which alternatively utilize transferrin or non-transferrin iron delivery pathways.
引用
收藏
页码:35 / 46
页数:12
相关论文
共 83 条
[1]   Transferrin receptor 1 [J].
Aisen, P .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (11) :2137-2143
[2]   Ferritin, iron homeostasis, and oxidative damage [J].
Arosio, P ;
Levi, S .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 (04) :457-463
[3]   Localisation of proteins of iron metabolism in the human placenta and liver [J].
Bastin, Judy ;
Drakesmith, Hal ;
Rees, Margaret ;
Sargent, Ian ;
Townsend, Alain .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (05) :532-543
[4]   MUTATION IN THE IRON-RESPONSIVE ELEMENT OF THE L-FERRITIN MESSENGER-RNA IN A FAMILY WITH DOMINANT HYPERFERRITINEMIA AND CATARACT [J].
BEAUMONT, C ;
LENEUVE, P ;
DEVAUX, I ;
SCOAZEC, JY ;
BERTHIER, M ;
LOISEAU, MN ;
GRANDCHAMP, B ;
BONNEAU, D .
NATURE GENETICS, 1995, 11 (04) :444-446
[5]   HEMOGLOBIN AND SERUM FERRITIN LEVELS IN MOTHERS AND INFANTS AT BIRTH [J].
BRATLID, D ;
MOE, PJ .
EUROPEAN JOURNAL OF PEDIATRICS, 1980, 134 (02) :125-127
[6]   INHIBITION OF PROLIFERATION AND DIFFERENTIATION DURING EARLY T-CELL DEVELOPMENT BY ANTITRANSFERRIN RECEPTOR ANTIBODY [J].
BREKELMANS, P ;
VANSOEST, P ;
LEENEN, PJM ;
VANEWIJK, W .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (11) :2896-2902
[7]   DISTRIBUTION OF FERRITIN RECEPTORS AND COATED PITS ON GIANT HELA-CELLS [J].
BRETSCHER, MS ;
THOMSON, JN .
EMBO JOURNAL, 1983, 2 (04) :599-603
[8]  
Camp V, 1996, ANAT EMBRYOL, V194, P341
[9]   TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis [J].
Chen, TT ;
Li, L ;
Chung, DH ;
Allen, CDC ;
Torti, SV ;
Torti, FM ;
Cyster, JG ;
Chen, CY ;
Brodsky, FM ;
Niemi, EC ;
Nakamura, MC ;
Seaman, WE ;
Daws, MR .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (07) :955-965
[10]   CELLULAR-DISTRIBUTION OF IRON, TRANSFERRIN, AND FERRITIN IN THE HYPOTRANSFERRINEMIC (HP) MOUSE-BRAIN [J].
DICKINSON, TK ;
CONNOR, JR .
JOURNAL OF COMPARATIVE NEUROLOGY, 1995, 355 (01) :67-80